GramEye
Funding Series
Series A
Funding Amount
¥149.7m
[data from INITIAL 2024 Dec]
Healthcare/Medtech

About

GramEye provides the world’s first AI medical device employing AI a​nd robotics technology to improve gram stains—a type of infectious disease test.

Milestone

In 2025, GramEye plans to update the current gram staining standard from four classifications to a single test that can classify over 20 categories, including bacterial species that are difficult to distinguish using traditional gram staining.
Visit Site
We're Here to Help
Have questions? Not sure where to start? Send us an email and let’s chat!
Email Us
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.